STIM News - Candlesense

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that impro...

Will this news prompt any change in analyst rating or target price for STIM? How might the compensation committee’s approval of these awards influence corporate governance perceptions? Are there any tax or regulatory implications associated with the awards that could affect cash flow?

Compensation

19 days ago